ArticleMolecular therapy oncolytics2019

An Engineered AAV6-Based Vaccine Induces High Cytolytic Anti-Tumor Activity by Directly Targeting DCs and Improves Ag Presentation.

Karina Krotova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.